China Resources Double-Crane Pharmaceutical Co Ltd (600062) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.040x

Based on the latest financial reports, China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a cash flow conversion efficiency ratio of 0.040x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥487.90 Million ≈ $71.40 Million USD) by net assets (CN¥12.16 Billion ≈ $1.78 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600062 net asset quality index to measure how much of total assets are equity-financed.

China Resources Double-Crane Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how China Resources Double-Crane Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check China Resources Double-Crane Pharmaceuti earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

China Resources Double-Crane Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China Resources Double-Crane Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
China Suntien Green Energy Corp Ltd SHG:600956	0.093x
Sims Metal Management Ltd F:I8M	0.025x
Wienerberger AG VI:WIE	0.081x
CREDITACCESS GRAMEEN LIMITED NSE:CREDITACC	0.043x
SASA Polyester Sanayi AS IS:SASA	0.052x
Shurgard Self Storage SA BR:SHUR	0.020x
Hainan Mining Co Ltd SHG:601969	0.076x
Rocket Internet SE HM:RKET	N/A

Annual Cash Flow Conversion Efficiency for China Resources Double-Crane Pharmaceutical Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of China Resources Double-Crane Pharmaceutical Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see 600062 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥11.11 Billion ≈ $1.63 Billion	CN¥1.83 Billion ≈ $267.07 Million	0.164x	+17.31%
2023-12-31	CN¥11.79 Billion ≈ $1.73 Billion	CN¥1.65 Billion ≈ $241.56 Million	0.140x	+11.98%
2022-12-31	CN¥10.73 Billion ≈ $1.57 Billion	CN¥1.34 Billion ≈ $196.33 Million	0.125x	-2.30%
2021-12-31	CN¥10.48 Billion ≈ $1.53 Billion	CN¥1.34 Billion ≈ $196.22 Million	0.128x	-11.76%
2020-12-31	CN¥9.38 Billion ≈ $1.37 Billion	CN¥1.36 Billion ≈ $199.03 Million	0.145x	-12.59%
2019-12-31	CN¥8.68 Billion ≈ $1.27 Billion	CN¥1.44 Billion ≈ $210.69 Million	0.166x	-10.67%
2018-12-31	CN¥7.91 Billion ≈ $1.16 Billion	CN¥1.47 Billion ≈ $214.97 Million	0.186x	+22.81%
2017-12-31	CN¥7.85 Billion ≈ $1.15 Billion	CN¥1.19 Billion ≈ $173.71 Million	0.151x	+38.03%
2016-12-31	CN¥7.04 Billion ≈ $1.03 Billion	CN¥771.25 Million ≈ $112.86 Million	0.110x	+0.52%
2015-12-31	CN¥6.43 Billion ≈ $941.48 Million	CN¥701.35 Million ≈ $102.63 Million	0.109x	-13.74%
2014-12-31	CN¥5.68 Billion ≈ $831.80 Million	CN¥718.38 Million ≈ $105.12 Million	0.126x	+23.46%
2013-12-31	CN¥5.34 Billion ≈ $780.86 Million	CN¥546.24 Million ≈ $79.93 Million	0.102x	+21.65%
2012-12-31	CN¥4.71 Billion ≈ $688.74 Million	CN¥396.05 Million ≈ $57.95 Million	0.084x	-28.55%
2011-12-31	CN¥4.34 Billion ≈ $635.56 Million	CN¥511.53 Million ≈ $74.85 Million	0.118x	-9.28%
2010-12-31	CN¥3.93 Billion ≈ $574.49 Million	CN¥509.67 Million ≈ $74.58 Million	0.130x	+34.17%
2009-12-31	CN¥3.53 Billion ≈ $517.25 Million	CN¥342.01 Million ≈ $50.05 Million	0.097x	-8.10%
2008-12-31	CN¥3.15 Billion ≈ $461.01 Million	CN¥331.71 Million ≈ $48.54 Million	0.105x	+5.74%
2007-12-31	CN¥2.36 Billion ≈ $346.03 Million	CN¥235.46 Million ≈ $34.45 Million	0.100x	-34.59%
2006-12-31	CN¥2.00 Billion ≈ $291.96 Million	CN¥303.71 Million ≈ $44.44 Million	0.152x	+111.19%
2005-12-31	CN¥1.94 Billion ≈ $283.78 Million	CN¥139.78 Million ≈ $20.45 Million	0.072x	-72.56%
2004-12-31	CN¥1.73 Billion ≈ $252.76 Million	CN¥453.72 Million ≈ $66.39 Million	0.263x	+202.75%
2003-12-31	CN¥1.72 Billion ≈ $251.20 Million	CN¥148.94 Million ≈ $21.79 Million	0.087x	-0.99%
2002-12-31	CN¥1.60 Billion ≈ $234.85 Million	CN¥140.63 Million ≈ $20.58 Million	0.088x	-7.41%
2001-12-31	CN¥1.49 Billion ≈ $218.03 Million	CN¥141.01 Million ≈ $20.63 Million	0.095x	-53.16%
2000-12-31	CN¥855.27 Million ≈ $125.15 Million	CN¥172.81 Million ≈ $25.29 Million	0.202x	+9.25%
1999-12-31	CN¥711.23 Million ≈ $104.08 Million	CN¥131.54 Million ≈ $19.25 Million	0.185x	+826.55%
1998-12-31	CN¥541.45 Million ≈ $79.23 Million	CN¥-13.78 Million ≈ $-2.02 Million	-0.025x	--

About China Resources Double-Crane Pharmaceutical Co Ltd

SHG:600062 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.60 Billion

CN¥17.77 Billion CNY

Market Cap Rank

#5288 Global

#915 in China

Share Price

CN¥17.11

Change (1 day)

-0.29%

52-Week Range

CN¥15.60 - CN¥21.22

All Time High

CN¥33.06